Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
04/17/2003 | WO2003031940A2 Structural and cytoskeleton-associated proteins |
04/17/2003 | WO2003031939A2 Protein modification and maintenance molecules |
04/17/2003 | WO2003031620A1 Novel class ii cytokine receptor |
04/17/2003 | WO2003031595A2 Molecules for disease detection and treatment |
04/17/2003 | WO2003031590A2 Nucleic acids encoding linked chromo/fluorescent domains and methods for using the same |
04/17/2003 | WO2003031578A2 Mammalian c-type lectins |
04/17/2003 | WO2003031577A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
04/17/2003 | WO2003031568A2 Intracellular signaling molecules |
04/17/2003 | WO2003031477A1 Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them |
04/17/2003 | WO2003031476A1 Antibody of human origin for inhibiting thrombocytes aggregation |
04/17/2003 | WO2003031475A2 Antibodies against kdr, their production and uses |
04/17/2003 | WO2003031466A2 Angiotensin peptide-carrier conjugates and uses thereof |
04/17/2003 | WO2003031464A2 Remodeling and glycoconjugation of peptides |
04/17/2003 | WO2003031462A2 Nogo receptor-mediated blockade of axonal growth |
04/17/2003 | WO2003030932A1 Attenuated mutant newcastle disease virus strains for in ovo vaccination, method for preparing and their use |
04/17/2003 | WO2003030835A2 Use of bispecific antibodies to regulate immune responses |
04/17/2003 | WO2003030833A2 Angiopoietin-2 specific binding agents |
04/17/2003 | WO2003030831A2 Treatment of prostate cancer by inhibitors of atp synthase |
04/17/2003 | WO2003000271A3 System and method for the large scale labeling of compounds with radiohalogens |
04/17/2003 | WO2002094985A3 Beta-secretase substrates and uses thereof |
04/17/2003 | WO2002094863A3 INTERFERON-α INDUCED GENE |
04/17/2003 | WO2002085943A3 Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof |
04/17/2003 | WO2002085930A3 Immunomodulating agents from parasitic worms and method for isolation thereof |
04/17/2003 | WO2002083727A3 Nucleic acid sequences of hyperplasies and tumors of the thyroid |
04/17/2003 | WO2002076486A3 Histidine-rich glycoprotein |
04/17/2003 | WO2002072636A3 Crystals of whole antibodies and fragments thereof and methods for making and using them |
04/17/2003 | WO2002070706A3 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
04/17/2003 | WO2002064615A3 Monoclonal antibodies to human immunodeficiency virus and uses thereof |
04/17/2003 | WO2002061070A3 Environmentally regulated genes, involved in the virulence of streptococcus suis |
04/17/2003 | WO2002051237A9 Helicobacter proteins, nucleic acids and uses thereof |
04/17/2003 | WO2002050289A9 Methods for the production of multimeric proteins, and related compositions |
04/17/2003 | WO2002050284A3 Oxidoreductases |
04/17/2003 | WO2002048315A3 Monoclonal antibody probe for detection of adhesins associated with mature endospores of pasteuria spp. |
04/17/2003 | WO2002033094A1 Antibody inhibiting vplf activity |
04/17/2003 | WO2002032445A3 Inhibition of the interaction between oxidized proteins and cd36 or the active mechanism thereof |
04/17/2003 | WO2002029036A3 Lipid metabolism enzymes |
04/17/2003 | WO2002024891A3 B7-like molecules and uses thereof |
04/17/2003 | WO2002020619A9 HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3) |
04/17/2003 | WO2002018576A3 Compositions and methods relating to lung specific genes |
04/17/2003 | WO2002018575A3 Genes expressed in the cell cycle |
04/17/2003 | WO2002018445A3 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design |
04/17/2003 | WO2002010402A3 Isolation of drosophila and human polynucleotides encoding par-1 kinase, polypeptides encoded by the polynucleotides and methods utilizing the polynucleotides and polypeptides |
04/17/2003 | WO2002004511A3 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS |
04/17/2003 | WO2002000721A3 Cytokine receptor zcytor17 |
04/17/2003 | WO2001085210A3 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth |
04/17/2003 | WO2001072773A3 Genes isolated from dendritic cells, gene products and methods employing the same |
04/17/2003 | WO1999065935A3 Fas peptides and antibodies for modulating apoptosis |
04/17/2003 | US20030074698 Method for modifying plant morphology, biochemistry and physiology |
04/17/2003 | US20030074680 Generation of animal food products having amplified ribs; obtain embryos, transform with vector, implant embryo into mammal, test progeny for expression of transgene, process progeny for food |
04/17/2003 | US20030074676 I0nduction of preferential immunoglobulin in mammal; obtain mammal, immunize with tumor necrosis factor, monitor expression of immunoglobulin in milk |
04/17/2003 | US20030073827 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
04/17/2003 | US20030073822 Blood group antigen fusion polypeptides and method of use thereof |
04/17/2003 | US20030073821 Antibody for use in human therapeutics and diagnostics |
04/17/2003 | US20030073813 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
04/17/2003 | US20030073810 Nucleotide sequence codin polypeptide for use in the diagnosis and treatment of nervous system and cancer disorders |
04/17/2003 | US20030073809 Nucleotide sequence codin polypeptide for use in the diagnosis and treatment of nervous system and cancer disorders |
04/17/2003 | US20030073657 Use of alpha 1-antichymotrypsin polypeptides, or nucleic acids encoding them, or of a cell which is expressing an ACT polypeptide, or a nucleic acid encoding it, for treatment and/or prevention of diabetes-associated and/or arterial poorly healing wounds and for identifying pharmacologically active substances |
04/17/2003 | US20030073655 Alzheimer's disease |
04/17/2003 | US20030073624 Anticancer agents; isolated nucleic acids; genetic engineering |
04/17/2003 | US20030073620 Genetic engineering; antibody binding to nucleic acid; disease therapy |
04/17/2003 | US20030073216 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
04/17/2003 | US20030073215 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
04/17/2003 | US20030073214 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
04/17/2003 | US20030073213 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
04/17/2003 | US20030073212 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
04/17/2003 | US20030073211 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
04/17/2003 | US20030073210 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
04/17/2003 | US20030073209 Infiltrating a plant tissue with a buffer solution; subjecting plant tissue and buffer solution to a substantially vacuum environment; removing tissue from the buffer solution; centrifuging the tissue to remove interstitial fluid; |
04/17/2003 | US20030073208 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative disorders |
04/17/2003 | US20030073195 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
04/17/2003 | US20030073187 Nucleotide sequences coding polypeptide for use in treatment and prevention of infection, induction of shock and inflammatory disease |
04/17/2003 | US20030073186 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
04/17/2003 | US20030073185 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
04/17/2003 | US20030073184 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
04/17/2003 | US20030073183 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
04/17/2003 | US20030073182 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
04/17/2003 | US20030073181 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
04/17/2003 | US20030073180 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
04/17/2003 | US20030073179 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
04/17/2003 | US20030073178 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
04/17/2003 | US20030073177 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
04/17/2003 | US20030073176 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
04/17/2003 | US20030073175 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
04/17/2003 | US20030073168 Polypeptide for use in the diagnosis, treatment and prevention of cardiovascular diseases |
04/17/2003 | US20030073167 DNA encoding SNORF36 receptors |
04/17/2003 | US20030073166 Haemophilus adherence and penetration proteins |
04/17/2003 | US20030073164 Prokaryotically produced antibodies and uses thereof |
04/17/2003 | US20030073148 Antibodies binding to human airway trypsin-like protease and methods for utilizing the same |
04/17/2003 | US20030073146 Methods for diagnosis of low grade astrocytoma |
04/17/2003 | US20030073142 Immunoglobulin E vaccines and methods of use thereof |
04/17/2003 | US20030073141 Monoclonal antibodies against a complex of human ACT and a serine protease |
04/17/2003 | US20030073137 Periostin-based diagnostic assays |
04/17/2003 | US20030073131 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and nervous system disorders |
04/17/2003 | US20030073130 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and nervous system disorders |
04/17/2003 | US20030073120 Nucleotide sequences coding polypeptide for use in the treatment of signal tranduction defects |
04/17/2003 | US20030073117 Novel protein and gene encoding the protein |
04/17/2003 | US20030073095 Nucleotide sequences coding bacterial protein for use in the treatment and prevention of bacterial infections |
04/17/2003 | US20030073080 Genetically engineered viral nucleotide sequences for use as tool in gene therapy and vaccine development |
04/17/2003 | US20030073079 Nucleotide sequences for use in the diagnosis, prevention and treatment of cell proliferative, skin and tumor disorders |
04/17/2003 | US20030073077 Nucleotide sequences for use in the diagnosis, prevention and treatment of cell proliferative, skin and tumor disorders |